Anticonvulsant activity of hydroalcoholic extract and aqueous fraction of Ebenus stellata in mice

Iranian Journal of Basic Medical Sciences

Volumn 15, Issue 3, 2012, Pages 811-819

  Khodaparast, Ayeh ^a,b   Sayyah, Mohammad ^a   Sardari, Soroush ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anticonvulsants; Ebenus stellata; Fabaceae

Indexed keywords

ALKALOID; DICHLOROMETHANE; EBENUS STELLATA EXTRACT; FLAVONOID; PENTETRAZOLE; PLANT EXTRACT; SAPONIN; STEROL; TANNIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; EBENUS STELLATA; ELECTRIC SHOCK; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHYTOCHEMISTRY; TONIC SEIZURE;

EID: 84862140997     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Vezzani M, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7:31-40.
2. Schmidt D, Loscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 2005; 46:858-877.
3. Schrire BD, Lewis GP, Lavin M. Biogeography of the Leguminosae. In: Lewis G, Schrire G, Mackinder B, Lock M, editors. Legumes of the world. First ed. Kew: Royal Botanic Gardens; 2005. p. 21-54.
4. Ojewole JA. Analgesic and anticonvulsant properties of Tetrapleura tetraptera (Taub) (Fabaceae) fruit aqueous extract in mice. Phytother Res 2005; 19: 1023-1029.
5. Ojewole JA. Anticonvulsant property of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) (Fabaceae) shoot aqueous extract. Brain Res Bull 2008; 75: 126-132.
6. Kasture VS, Chopde CT, Deshmukh VK. Anticonvulsive activity of Albizzia lebbeck, Hibiscus rosa sinesis and Butea monosperma in experimental animals. J Ethnopharmacol 2000; 71:65-75.
7. Kasture VS, Deshmukh VK, Chopde CT. Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytother Res 2002; 16:455-460.
8. Kasture VS, Kasture SB, Chopde CT. Anticonvulsive activity of Butea monosperma flowers in laboratory animals. Pharmacol Biochem Behav 2002; 72:965-972.
9. Haruna AK. Depressant and anticonvulsant properties of the root decoction of Afrormosia laxiflora (Leguminosae). Phytother Res 2000; 14:57-59.
10. Vasconcelos SM, Lima NM, Sales GT, Cunha GM, Aguiar LM, Silveira ER. Anticonvulsant activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu. J Ethnopharmacol 2007; 110:271-274.
11. Van Wyk BE, Albrecht C. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J Ethnopharmacol 2008; 119:620-629.
12. Salih MA, Mustafa AA. A substance in broad beans (Vicia faba) is protective against experimentally induced convulsions in mice. Epilepsy Behav 2008; 12:25-29.
13. Aldarmaa J, Liu Z, Long J, Mo X, Ma J, Liu J. Anti-convulsant effect and mechanism of Astragalus mongholicus extract in vitro and in vivo: protection against oxidative damage and mitochondrial dysfunction. Neurochem Res 2010; 35: 33-41.
14. Ambawade SD, Kasture VS, Kasture SB. Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra. Indian J Pharmacol 2002; 4:251-255.
15. Yazdi A, Sardari S, Sayyah M, Hassanpour Ezzati M. Evaluation of the anticonvulsant activity of the leaves of Glycyrrhiza glabra var. glandulifera grown in Iran, as a possible renewable source for anticonvulsant compounds. Iran J Pharm Res 2011; 10:75-82.
16. Wagner H, Bladt S. Plant Drug Analysis. 2nd ed. Berlin: Springer; 1996. p. 299-304.
17. Stahl E. Thin Layer Chromatography. 2nd ed. Berlin: Springer; 1969. p. 52-85.
18. Litchfield ST, Wilcoxon F.A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96:99-105.
19. Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988; 2:145-181.
20. Gareri P, Condorelli D, Belluardo N, Gratteri S, Ferreri G, Donato Di Paola E, et al. Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol 2004; 484:49-56.
21. Nassiri-Asl M, Shariati-rad S, Zamansoltani F. Anticonvulsant effects of intracerebroventricular administration of rutin in rats. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:989-993.
22. Pal D, Sannigrahi S, Mazumder UK. Analgesic and anticonvulsant effects of saponin isolated from the leaves of Clerodendrum infortunatum Linn. in mice. Indian J Exp Biol 2009; 47:743-747.
23. Chindo BA, Anuka JA, McNeil L, Yaro AH, Adamu SS, Amos S, et al. Anticonvulsant properties of saponins from Ficus platyphylla stem bark. Brain Res Bull 2010; 78:276-282.
24. Bhutada P, Mundhada Y, Bansod K, Dixit P, Umathe S, Mundhada D. Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav 2010; 18:207-210.
25. Coulter DA, Hugenard JR, Prince DA. Characterization of the ethosuximide reduction in low-threshold calcium current in thalamic neurons. Ann Neurol 1989; 25:582-593.
26. Macdonald RL, Kelly KM. Antiepileptic drugs mechanisms of action. Epilepsia 1995; 36:S2-S12.
27. Velisek L, Kusa R, Kulovana M, Mares P. Excitatory amino acid antagonists and pentylenetetrazole-induced seizures during ontogenesis. I. The effects of 2-amino-7-phosphonoheptanoate. Life Sci 1990; 46:1349-1357.
28. Ren L, Wang F, Xu Z, Chan WM, Zhao C, Xue H. GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone. Biochem Pharmacol 2010; 79:1337-1344.
29. Wang F, Xu Z, Ren L, Tsang SY, Xue H. GABAA receptor subtype selectivity underlying selective anxiolytic effect of baicalin. Neuropharmacology 2008; 55:1231-1237.
30. Nilsson J, Sterner O. Modulation of GABA (A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site. Curr Drug Targets 2011; 12:1674-1688. Review.
31. Zhang XN, Li JM, Yang Q, Feng B, Liu SB, Xu ZH, et al. Anti-apoptotic effects of hyperoside via inhibition of NR2B-containing NMDA receptors. Pharmacol Rep 2010; 62: 949-955.
32. Huang R, Singh M, Dillon GH. Genistein directly inhibits native and recombinant NMDA receptors. Neuropharmacology 2010; 58:1246-1251.
33. Faggion SA, Cunha AO, Fachim HA, Gavin AS, dos Santos WF, Pereira AM, et al. Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-α-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex Benth (Leguminosae-Papilionaceae). Epilepsy Behav 2011; 20:441-446.
34. Bhutada P, Mundhada Y, Bansod K, Dixit P, Umathe S, Mundhada D. Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav 2010; 18:207-210.
35. Longhi-Balbinot DT, Pietrovski EF, Gadotti VM, Martins DF, Facundo VA, Santos AR. Spinal antinociception evoked by the triterpene 3beta, 6beta, 16beta-trihydroxylup-20(29)-ene in mice: evidence for the involvement of the glutamatergic system via NMDA and metabotropic glutamate receptors. Eur J Pharmacol 2009; 623:30-36.
36. Kim S, Kim T, Ahn K, Park WK, Nah SY, Rhim H. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun 2004; 323:416-424.
37. Fülep GH, Hoesl CE, Höfner G, Wanner KT. New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids. Eur J Med Chem 2006; 41: 809-824.
38. Chindo BA, Anuka JA, McNeil L, Yaro AH, Adamu SS, Amos S, et al. Anticonvulsant properties of saponins from Ficus platyphylla stem bark. Brain Res Bull 2009; 78:276-282.